Patent · US Active

Negative allosteric modulators of metabotropic glutamate receptor 3

US10399948B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

VANDERBILT UNIVERSITY · US

Inventors

P. Jeffrey Conn · Brentwood, US
Craig W. Lindsley · Brentwood, US
Kyle A. Emmitte · Durham, US
Julie L. Engers · Brentwood, US
Katrina A. Bollinger · Murfreesboro, US
Megan M. Breiner · Memphis, US

Key dates

Filing date	Feb 10, 2016
Grant date	Sep 3, 2019
Priority date	—
Expiry date	Feb 10, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Described are negative allosteric modulators of metabotropic glutamate receptor 3 (mGlu3), pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating depression, cognitive disorders, schizophrenia, Alzheimer's disease, or cancer in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.